Literature DB >> 9131439

Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.

B Naume1, E Borgen, K Beiske, T K Herstad, G Ravnås, A Renolen, S Trachsel, K Thrane-Steen, S Funderud, G Kvalheim.   

Abstract

Detection of isolated tumor cells (TC) in bone marrow (BM) from patients with breast cancer is usually accomplished by immunocytochemical (ICC) analysis of up to 2 X 10(6) mononuclear cells (MNC). However, this method is cumbersome if large numbers of BM cells (i.e. > 1 X 10(7) cells) are to be analyzed. This emphasizes the need for TC enrichment strategies. This report describes immunomagnetic separation (IMS) techniques for enrichment and detection of viable breast carcinoma cells in BM and peripheral blood (PB). The positive IMS technique was performed by incubation of MNC with 2.8 microns magnetic particles (rat antimouse IgG1 M280-Dynabeads) coated with monoclonal antibody (mAb) against epithelial surface antigens. The rosetted tumor cells were then visualized by ICC staining using alkaline phosphatase-conjugated A45-B/B3 anticytokeratin mAb (Fab). The negative IMS technique was performed by incubation of MNC with anti-CD45-coated M450-Dynabeads (4.5 microns), followed by ICC staining of the nonrosetted cells. When 1000, 100, and 10 breast carcinoma cells were mixed with 1 X 10(7) MNC, an average of 748 (n = 9), 70 (n = 10), and 7.8 TC (n = 8), respectively, were detected with the positive IMS technique. With the negative IMS technique, 648 (n = 8), 57.8 (n = 6), and 7.3 TC (n = 6), respectively, were detected. The analysis of 1 X 10(7) MNC with the IMS techniques was compared with the ICC analysis of 2 X 10(6) unseparated MNC. A mean 3.7-fold (range 1.5-6.4) to 4.2-fold (2.5-8.2) (positive IMS) and 3.1-fold (range 2.0-5.0) to 3.8-fold (2.0-6.0) (negative IMS) higher TC detection frequency was achieved after enrichment by IMS in experiments with 100 and 1000 TC/10(7) MNC. The IMS techniques were used for examination of BM samples from locally advanced breast cancer patients. A 5.3-fold mean increase (range 2.1-13.3) in the number of TC detected was obtained when the use of positive and negative IMS together was compared with the direct ICC analysis of unseparated MNC (n = 11). Enrichment of TC by IMS techniques enables us to examine large numbers of MNC from BM or PB, which can result in the detection and characterization of minimal residual disease with increased sensitivity and specificity.

Entities:  

Mesh:

Year:  1997        PMID: 9131439     DOI: 10.1089/scd.1.1997.6.103

Source DB:  PubMed          Journal:  J Hematother        ISSN: 1061-6128


  18 in total

1.  Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

Authors:  M Partridge
Journal:  Ann R Coll Surg Engl       Date:  1999-01       Impact factor: 1.891

2.  Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells.

Authors:  J H Clement; M Schwalbe; N Buske; K Wagner; M Schnabelrauch; P Görnert; K O Kliche; K Pachmann; W Weitschies; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-24       Impact factor: 4.553

Review 3.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

4.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

5.  Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells.

Authors:  R L Houghton; D C Dillon; D A Molesh; B K Zehentner; J Xu; J Jiang; C Schmidt; A Frudakis; E Repasky; A Maltez Filho; M Nolasco; R Badaro; X Zhang; P C Roche; D H Persing; S G Reed
Journal:  Mol Diagn       Date:  2001-06

6.  Detection of circulating melanoma cells by immunomagnetic cell sorting.

Authors:  A Benez; A Geiselhart; R Handgretinger; U Schiebel; G Fierlbeck
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

7.  Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.

Authors:  Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

Review 8.  Circulating tumors cells as biomarkers: progress toward biomarker qualification.

Authors:  Daniel C Danila; Klaus Pantel; Martin Fleisher; Howard I Scher
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

9.  Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.

Authors:  A Forus; H K Høifødt; G E Overli; O Myklebost; O Fodstad
Journal:  Mol Pathol       Date:  1999-04

Review 10.  Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

Authors:  Ashutosh Agarwal; Marija Balic; Dorraya El-Ashry; Richard J Cote
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.